IP Library › Granted Patent US 9,790,183
Granted Patent B2
US 9,790,183 · App. 15/015,586 · Granted Oct 17, 2017

Pyridyl inhibitors of hedgehog signalling

Inventors: Janet L. Gunzner-Toste (Piedmont, CA); Daniel Sutherlin (Burlingame, CA); Mark S. Stanley (Pacifica, CA); Liang Bao (Freemont, CA); Georgette M. Castanedo (Redwood City, CA); Rebecca L. Lalonde (Portland, OR); Shumei Wang (Foster City, CA); Mark E. Reynolds (Millbrae, CA); Scott J. Savage (Burlingame, CA); Kimberly Malesky (Boston, MA); Michael S. Dina (Daly City, CA); Michael F. T. Koehler (Palo Alto, CA)
Assignee: GENENTECH, INC.
C07D213/16C07D213/38C07D213/40C07D213/56C07D213/70C07D213/75C07D213/81C07D213/82C07D401/12C07D401/14C07D405/12C07D409/12C07D413/12C07D417/04C07D417/12C07F9/588
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,790,183
App. No.
15/015,586
Granted
Oct 17, 2017
Kind
B2
Abstract

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R 1 , R 2 , R 3 , R 4 , m and n are as described herein.

Claims (83)

1. A method of inhibiting hedgehog pathway signaling in a cell comprising contacting said cell with an effective amount of a compound of formula I:

wherein

A is a carbocycle or heterocycle;

X is alkylene, *NR 4 C(O), *NR 4 C(S), *N(C(O)R 1 )C(O), *NR 4 SO, *NR 4 SO 2 , *NR 4 C(O)NH, *NR 4 C(S)NH, *C(O)NR 4 , *C(S)NR 4 , *NR 4 PO or *NR 4 PO(OH), wherein * indicates the point of attachment to ring A;

Y is absent, CHR 4 , O, S, SO, SO 2 or NR 4 ;

R 1 is selected from the group consisting of alkyl, a carbocycle or a heterocycle each of which is optionally substituted with hydroxyl, halogen, amino, carboxyl, amidino, guanidino, carbonyl, nitro, cyano, acyl, alkyl, haloalkyl, sulfonyl, sulfinyl, alkoxy, akylthio, carbamoyl, acylamino, sulfamoyl, sulfonamide, a carbocycle or a heterocycle; wherein said amino, amidino, alkyl, acyl, sulfonyl, sulfinyl, alkoxy, alkylthio, carbamoyl, acylamino, sulfamoyl, sulfonamide, carbocycle and heterocycle substituent is optionally substituted with, halogen, haloalkyl, hydroxyl, carboxyl, carbonyl, or an amino, alkyl, alkoxy, acyl, sulfonyl, sulfinyl, phosphinate, carbocycle or heterocycle that is optionally substituted with hydroxyl, carboxyl, carbonyl, amino, halogen, haloalkyl, alkyl, alkoxy, alkylthio, sulfonyl, sulfinyl, acyl, a carbocycle or a heterocycle;

R 2 is halogen, hydroxyl, alkyl, acyl or alkoxy, wherein each alkyl, acyl and alkoxy is optionally substituted with hydroxyl, halogen, amino, nitro, alkyl, acyl, alkylsulfonyl or alkoxy;

R 3 is halogen, hydroxyl, carboxyl, alkyl, acyl, alkoxy, alkoxycarbonyl, carbamoyl, alkylsulfide, sulfinyl, sulfonyl, a carbocycle or a heterocycle wherein each alkyl, acyl, alkoxy, alkoxycarbonyl, carbamoyl, alkylsulfide, sulfinyl, sulfonyl, carbocycle and heterocycle is optionally substituted with hydroxyl, halogen, amino, nitro, alkyl, acyl, sulfonyl or alkoxy;

R 4 is H or alkyl;

m is 0-3;

n is 0-3;

or a salt or solvate thereof.

2. The method according to claim 1 , wherein A is a ring selected from the group consisting of A 1 , A 2 , A 3 , A 4 A 5 , A 6 and A 7 :

wherein Z 1 is O, S or NR 5 wherein R 5 is H or alkyl; Z 2 is CH, CR 2′ or N; R 2 is halogen, hydroxyl, alkyl or alkoxy; R 2′ is H, halogen, hydroxyl, alkyl or alkoxy; and n is 0-3.

3. The method according to claim 2 , wherein A is ring A 1 wherein Z 1 is S and Z 2 is CH or N.

4. The method according to claim 2 , wherein A is the ring A 2 .

5. The method according to claim 2 , wherein R 2 or R 2 ′ is Cl.

6. The method according to claim 1 , wherein A is A 1a , A 1b , A 2a , A 3a , A 3b , A 4a , A 5a , A 6a , A 7a :

7. The method according to claim 1 , wherein X is *NR 4 C(O).

8. The method according to claim 1 , wherein X is *NR 4 SO 2 .

9. The method according to claim 7 , wherein R 4 is H or Me.

10. The method according to claim 9 , wherein R 4 is H.

11. The method according to claim 1 , wherein R 3 is Me or F.

12. The method according to claim 1 , wherein R 3 is Me and m is 1 or 2.

13. The method according to claim 1 , wherein R 3 is F and m is 1 or 2.

14. The method according to claim 1 , wherein m is 0.

15. The method according to claim 1 , wherein R 1 is selected from the group consisting of formulae IIa-IIo:

wherein

W is O, S or NR 7 wherein R 7 is H, alkyl, acyl, a carbocycle or a heterocycle wherein said alkyl carbocycle and heterocycle are each optionally substituted with 1-3 amino, halogen, hydroxyl and haloalkyl;

R 6 in each instance is independently hydroxyl, halogen, amino, carbonyl, nitro, cyano, acyl, alkyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, alkoxy, alkylcarbamoyl, alkanoylamine, alkylsulfamoyl, alkylsulfonamide, a carbocycle or a heterocycle; wherein said amino, alkyl, carbonyl, acyl, sulfonyl, alkylsulfonyl, alkylsulfinyl, alkoxy, alkylcarbamoyl, alkanoylamine, alkylsulfamoyl, alkylsulfonamide, carbocycle and heterocycle substituent is optionally substituted with amino, halogen, hydroxyl, carbonyl, or a carbocycle or heterocycle that is optionally substituted with hydroxyl, amino, halogen, haloalkyl, alkyl, alkoxy or acyl; and

o is 0-3.

16. The method according to claim 15 , wherein R 1 is the group of formula IIa.

17. The method according to claim 16 , wherein R 6 is alkoxy and o is 1 or 2.

18. The method according to claim 16 , wherein R 1 is selected from the group of formulae IIa 1 -IIa 28 :

19. The method according to claim 16 , wherein A is

20. The method according to claim 16 , wherein A is

21. The method according to claim 16 , wherein R 3 is methyl or F.

22. The method according to claim 3 , wherein m is 0.

23. The method according to claim 3 , wherein X is *NR 4 C(O).

24. The method according to claim 15 , wherein R 1 is the group of formula IIb.

25. The method according to claim 24 , wherein R 6 is alkyl or haloalkyl.

26. The method according to claim 24 , wherein R 1 is the group of the formula

27. The method according to claim 24 , wherein A is

28. The method according to claim 24 , wherein A is

29. The method according to claim 24 , wherein m is 0.

30. The method according to claim 24 , wherein X is *NR 4 C(O).

31. The method according to claim 1 , wherein said compound is of the following formula

wherein

X, R 3 , and m are as defined in claim 1 ;

R 8 is a halogen;

ring B is phenyl or pyridyl,

o is 1-3, and

each R 6 independently is optionally substituted alkyl, halogen, alkoxy, carbonyl, heterocycle, alkylamino, arylamino, alkylcarbamoyl, alkylsulfamoyl, or sulfonyl.

32. The method according to claim 31 , wherein each R 6 independently is methyl, trifluoromethyl, dimethylaminomethyl, piperidinylmethyl, morpholinomethyl, thiomorpholinomethyl, chloro, methoxy, morpholinocarbonyl, acetyl, morpholino, N-methyl-piperazin-4-yl, N-acetyl-piperazin-4-yl, 1H-1,2,4-triazole, i-butylamino, benzylamino, hydroxyethylamino, methoxyethylamino, dimethylaminoethylamino, morpholinoethylamino, morpholinopropylamino, pyrrolidin-2-one-substituted propylamino, imidazole-ethylamino, imidazole-propylamino, phenylamino, dimethylcarbamoyl, i-butylaminocarbonyl, propylaminosulfonyl, i-butylaminosulfonyl, dimethylaminosulfonyl, dimethylaminoethyl hydroxyethylaminosulfonyl, methoxyethylaminosulfonyl, methoxypropylaminosulfonyl, methylsulfonylethylaminosulfonyl, imidazole-substituted propylaminosulfonyl, hydroxypropylaminosulfonyl, 2-hydroxypropylaminosulfonyl, methylsulfonyl, ethylsulfonyl, aminosulfonyl, dimethylaminopropylsulfonyl, N-methyl-piperazin-4-yl-sulfonyl, morpholino-4-yl-sulfonyl, or trifluoromethylsulfonyl.

33. The method according to claim 31 , wherein m is 0.

34. The method according to claim 31 , wherein R 8 is Cl.

35. The method according to claim 31 , wherein o is 2.

36. The method according to claim 31 , wherein one R 6 is Cl.

37. The method according to claim 31 , wherein m is 0, o is 2, R 8 is Cl, one R 6 is Cl and one R 6 is an optionally substituted sulfonyl.

38. The method according to claim 1 , wherein

A is substituted benzene;

X is *NR 4 C(O) or *NR 4 C(S);

Y is absent;

R 1 is aryl or heteroaryl, each of which is optionally substituted; and

R 2 is halogen, or alkyl substituted with halogen and an R 2 is in the o-position on said A benzene relative to pyridyl.

39. The method according to claim 38 , wherein R 4 is H or methyl.

40. The method according to claim 39 , wherein R 4 is H.

41. The method according to claim 38 , wherein R 1 is substituted.

42. The method according to claim 41 , wherein R 1 is substituted phenyl or substituted pyridyl.

43. The method according to claim 42 , wherein R 1 is substituted phenyl.

44. The method according to claim 38 , wherein said compound is a compound of formula Ib

wherein R 3 is absent or is methyl,

R 8 is halogen,

X is *NR 4 C(O),

m is 0-3,

R 4 is H or alkyl, and

R 1 is aryl or heteroaryl, each of which is optionally substituted.

45. The method according to claim 44 , wherein R 1 is substituted phenyl or substituted pyridyl.

46. The method according to claim 45 , wherein R 4 is H, m is 0 and R 8 is Cl.

47. The method according to claim 45 , wherein said substituted phenyl or pyridyl R 1 group comprises —SO 2 —.

48. A method of inhibiting hedgehog pathway signaling in a cell comprising contacting said cell with an effective amount of a compound of the formula:

or a salt or solvate thereof.

49. The method according to claim 38 , wherein said compound is of the formula

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2025
From: CURIS, INC.
To: CURIS ROYALTY LLC
Reel/Frame 072976/0431 →
Continuity (4)
Division 12960609 · Dec 6, 2010
Division 11217663 · Sep 2, 2005
Provisional Application 60607367 · Sep 2, 2004
Related Publication 20160152569A1 · Jun 2, 2016